977 related articles for article (PubMed ID: 3900132)
1. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
[TBL] [Abstract][Full Text] [Related]
2. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
3. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.
Ciabattoni G; Cinotti GA; Pierucci A; Simonetti BM; Manzi M; Pugliese F; Barsotti P; Pecci G; Taggi F; Patrono C
N Engl J Med; 1984 Feb; 310(5):279-83. PubMed ID: 6361565
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
5. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
[TBL] [Abstract][Full Text] [Related]
6. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
Yoshida T; Ichikawa Y; Tojo T; Homma M
Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
8. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
9. Altered renal and platelet arachidonic acid metabolism in cirrhosis.
Laffi G; La Villa G; Pinzani M; Ciabattoni G; Patrignani P; Mannelli M; Cominelli F; Gentilini P
Gastroenterology; 1986 Feb; 90(2):274-82. PubMed ID: 3079716
[TBL] [Abstract][Full Text] [Related]
10. Increased renal thromboxane production in murine lupus nephritis.
Kelley VE; Sneve S; Musinski S
J Clin Invest; 1986 Jan; 77(1):252-9. PubMed ID: 3455932
[TBL] [Abstract][Full Text] [Related]
11. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants.
Ylikorkala O; Pekonen F; Viinikka L
J Clin Endocrinol Metab; 1986 Dec; 63(6):1307-12. PubMed ID: 3536979
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
Ylikorkala O; Huttunen K; Järvi J; Viinikka L
Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
[TBL] [Abstract][Full Text] [Related]
15. Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation.
Noris M; Benigni A; Siegler R; Gaspari F; Casiraghi F; Mancini ML; Remuzzi G
Am J Kidney Dis; 1992 Aug; 20(2):144-9. PubMed ID: 1496967
[TBL] [Abstract][Full Text] [Related]
16. [The effect of plasma from women with preeclampsia on endothelial cells activators in vitro].
Zhou L; Yang M; Li D
Zhonghua Fu Chan Ke Za Zhi; 2000 Jul; 35(7):401-3. PubMed ID: 11776183
[TBL] [Abstract][Full Text] [Related]
17. Increased synthesis of prostacyclin and thromboxane in human ovarian malignancy.
Aitokallio-Tallberg AM; Viinikka LU; Ylikorkala RO
Cancer Res; 1988 May; 48(9):2396-8. PubMed ID: 3281748
[TBL] [Abstract][Full Text] [Related]
18. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
Weber C; Beetens JR; Tegtmeier F; Van Rooy P; Vercammen E; Wouters L; De Clerck F
Thromb Haemost; 1992 Aug; 68(2):214-20. PubMed ID: 1412169
[TBL] [Abstract][Full Text] [Related]
19. [Urinary 11-dehydrothromboxane B2 and 6-keto-prostaglandin F1 alpha in normal pregnant women and in women complicated with pregnancy-induced hypertension].
Yoshimura T; Okazaki T; Suzuki A
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):657-62. PubMed ID: 1506726
[TBL] [Abstract][Full Text] [Related]
20. Prostacyclin and thromboxane A2 moderate postischemic renal failure.
Lelcuk S; Alexander F; Kobzik L; Valeri CR; Shepro D; Hechtman HB
Surgery; 1985 Aug; 98(2):207-12. PubMed ID: 3895535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
